Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
17 Mar 2024
17 Mar 2024
Historique:
received:
14
02
2024
accepted:
14
02
2024
medline:
18
3
2024
pubmed:
18
3
2024
entrez:
18
3
2024
Statut:
aheadofprint
Résumé
The Evaluation of Groin Lymphadenectomy Extent for Melanoma (EAGLE FM) study sought to address the question of whether to perform inguinal (IL) or ilio-inguinal lymphadenectomy (I-IL) for patients with inguinal nodal metastatic melanoma who have no clinical or imaging evidence of pelvic disease. Primary outcome measure was disease-free survival at 5 years, and secondary endpoints included lymphoedema. EAGLE FM was designed to recruit 634 patients but closed with 88 patients randomised because of slow recruitment and changes in melanoma management. Lymphoedema assessments occurred preoperatively and at 6, 12, 18, and 24 months postoperatively. Lymphoedema was defined as Inter-Limb Volume Difference (ILVD) > 10%, Lymphoedema Index (L-Dex Prevalence of leg lymphoedema between the two groups was similar but numerically higher for I-IL at all time points in the first 24 months of follow-up; highest at 6 months (45.9% IL [CI 29.9-62.0%], 54.1% I-IL [CI 38.0-70.1%]) and lowest at 18 months (18.8% IL [CI 5.2-32.3%], 41.4% I-IL [CI 23.5-59.3%]). Median ILVD at 24 months for those affected by lymphoedema was 14.5% (IQR 10.6-18.7%) and L-Dex Despite a trend for patients who had I-IL to have greater lymphoedema prevalence than IL in the first 24 months after surgery, our study's small sample did not have the statistical evidence to support an overall difference between the surgical groups.
Sections du résumé
BACKGROUND
BACKGROUND
The Evaluation of Groin Lymphadenectomy Extent for Melanoma (EAGLE FM) study sought to address the question of whether to perform inguinal (IL) or ilio-inguinal lymphadenectomy (I-IL) for patients with inguinal nodal metastatic melanoma who have no clinical or imaging evidence of pelvic disease. Primary outcome measure was disease-free survival at 5 years, and secondary endpoints included lymphoedema.
METHODS
METHODS
EAGLE FM was designed to recruit 634 patients but closed with 88 patients randomised because of slow recruitment and changes in melanoma management. Lymphoedema assessments occurred preoperatively and at 6, 12, 18, and 24 months postoperatively. Lymphoedema was defined as Inter-Limb Volume Difference (ILVD) > 10%, Lymphoedema Index (L-Dex
RESULTS
RESULTS
Prevalence of leg lymphoedema between the two groups was similar but numerically higher for I-IL at all time points in the first 24 months of follow-up; highest at 6 months (45.9% IL [CI 29.9-62.0%], 54.1% I-IL [CI 38.0-70.1%]) and lowest at 18 months (18.8% IL [CI 5.2-32.3%], 41.4% I-IL [CI 23.5-59.3%]). Median ILVD at 24 months for those affected by lymphoedema was 14.5% (IQR 10.6-18.7%) and L-Dex
CONCLUSIONS
CONCLUSIONS
Despite a trend for patients who had I-IL to have greater lymphoedema prevalence than IL in the first 24 months after surgery, our study's small sample did not have the statistical evidence to support an overall difference between the surgical groups.
Identifiants
pubmed: 38494565
doi: 10.1245/s10434-024-15149-4
pii: 10.1245/s10434-024-15149-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Crown.
Références
Pasquali S, Spillane AJ, De Wilt JH, et al. Surgeons’ opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey. Ann Surg Oncol. 2012;19(13):4322–9.
doi: 10.1245/s10434-012-2483-3
pubmed: 22805861
Hughes T, Thomas J. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86(12):1493–8.
doi: 10.1046/j.1365-2168.1999.01316.x
pubmed: 10594495
Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the multicenter selective lymphadenectomy trial (I). Ann Surg Oncol. 2010;17:3324–9.
doi: 10.1245/s10434-010-1203-0
pubmed: 20614193
pmcid: 2970739
Soderman M, Thomsen JB, Sorensen JA. Complications following inguinal and ilioinguinal lymphadenectomies: a meta-analysis. J Plast Surg Hand Surg. 2016;50(6):315–20.
doi: 10.3109/2000656X.2016.1173560
pubmed: 27146716
Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg. 2008;248(2):286–93.
doi: 10.1097/SLA.0b013e31817ed7c3
pubmed: 18650640
Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17:2764–72.
doi: 10.1245/s10434-010-1026-z
pubmed: 20336388
pmcid: 2943041
Gjorup CA, Groenvold M, Hendel HW, et al. Health-related quality of life in melanoma patients: impact of melanoma-related limb lymphoedema. Eur J Cancer. 2017;85:122–32.
doi: 10.1016/j.ejca.2017.07.052
pubmed: 28918186
Henderson MA, Burmeister BH, Ainslie J, et al. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol. 2015;16(9):1049–60.
doi: 10.1016/S1470-2045(15)00187-4
pubmed: 26206146
Küpper S, Austin JL, Dingley B, et al. Extent of groin dissection in melanoma: a mixed-methods, population-based study of practice patterns and outcomes. Curr Oncol. 2021;28(6):5422–33.
doi: 10.3390/curroncol28060452
pubmed: 34940091
pmcid: 8700358
Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–22.
doi: 10.1056/NEJMoa1613210
pubmed: 28591523
pmcid: 5548388
Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757–67.
doi: 10.1016/S1470-2045(16)00141-8
pubmed: 27161539
Saghaei M. An overview of randomization and minimization programs for randomized clinical trials. J Med Signals Sensors. 2011;1(1):55.
doi: 10.4103/2228-7477.83520
Australasian Lymphology Association. Position Statement: Circumferential measurement guideline. 2012.
Australasian Lymphology Association. Guideline for A National standard technique of measurement of lymphoedematous limbs. 2004.
Lymphoedema Framework. Best Practice for the Management of Lymphoedema. International Consensus. 2006.
Ward L, Dylke E, Czerniec S, Isenring E, Kilbreath S. Reference ranges for assessment of unilateral lymphedema in legs by bioelectrical impedance spectroscopy. Lymph Res Biol. 2011;9(1):43–6.
doi: 10.1089/lrb.2010.0024
Sitzia J, Stanton A, Badger C. A review of outcome indicators in the treatment of chronic limb oedema. Clin Rehab. 1997;11(3):181–91.
doi: 10.1177/026921559701100301
Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R. A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema. 2010;5(1):26–37.
Maruccia M, Elia R, Ciudad P, et al. Postmastectomy upper limb lymphedema: combined vascularized lymph node transfer and scar release with fat graft expedites surgical and patients’ related outcomes: a retrospective comparative study. J Plastic Reconstr Aesth Surg. 2019;72(6):892–901.
doi: 10.1016/j.bjps.2019.01.029
Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A. Cancer-associated secondary lymphoedema. Nat Rev Dis Primers. 2019;5(1):1–16.
doi: 10.1038/s41572-019-0072-5
Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(S8):2191–200.
doi: 10.1002/cncr.27476
pubmed: 22488693
Stout NL, Pfalzer LA, Springer B, et al. Breast cancer–related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012;92(1):152–63.
doi: 10.2522/ptj.20100167
pubmed: 21921254
Ridner SH, Dietrich MS, Spotanski K, et al. A prospective study of L-Dex values in breast cancer patients pretreatment and through 12 months postoperatively. Lymph Res Biol. 2018;16(5):435–41.
doi: 10.1089/lrb.2017.0070
Gjorup CA, Hendel HW, Klausen TW, Zerahn B, Hölmich LR. Reference values for assessment of unilateral limb lymphedema with dual-energy x-ray absorptiometry. Lymph Res Biol. 2018;16(1):75–84.
doi: 10.1089/lrb.2016.0064
Borčinová M, Ragosch V, Jarkovský J, et al. Challenges in lower limb lymphoedema assessment based on limb volume change: lessons learnt from the SENTIX prospective multicentre study. Gynecol Oncol. 2022;164(1):76–84.
doi: 10.1016/j.ygyno.2021.10.089
pubmed: 34763939
González-Loyola A, Petrova TV. Development and aging of the lymphatic vascular system. Adv Drug Delivery Rev. 2021;169:63–78.
doi: 10.1016/j.addr.2020.12.005
Ruckley CV, Evans CJ, Allan PL, Lee AJ, Fowkes FGR. Chronic venous insufficiency: clinical and duplex correlations: the Edinburgh Vein Study of venous disorders in the general population. J Vasc Surg. 2002;36(3):520–5.
doi: 10.1067/mva.2002.126547
pubmed: 12218976
Stuiver MM, De Rooij J, Lucas C, et al. No evidence of benefit from class-II compression stockings in the prevention of lower-limb lymphedema after inguinal lymph node dissection: results of a randomized controlled trial. Lymphology. 2013;46(3):120–31.
pubmed: 24645535
Paramanandam VS, Dylke E, Clark GM, et al. Prophylactic use of compression sleeves reduces the incidence of arm swelling in women at high risk of breast cancer–related lymphedema: a randomized controlled trial. J Clin Oncol. 2022;40(18):2004–12.
doi: 10.1200/JCO.21.02567
pubmed: 35108031
Cataldo J, de Godoy JP, De Barros N. The use of compression stockings for venous disorders in Brazil. Phlebology. 2012;27(1):33–7.
doi: 10.1258/phleb.2011.010088
pubmed: 21765190
pmcid: 3257001
Bar L, Marks D, Brandis S. Developing a suite of resources to improve patient adherence to compression stockings: application of behavior change theory. Patient Preference Adherence. 2022. https://doi.org/10.2147/PPA.S390123 .
doi: 10.2147/PPA.S390123
Erdinç Gündüz N, Şahin E, Dilek B, Ellidokuz H, Akalın E. Adherence to compression garment wear and associated factors among patients with breast cancer-related lymphedema: a pilot study from a Turkish tertiary center. Lymph Res Biol. 2022;20:665.
doi: 10.1089/lrb.2021.0091
Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM. Patient perceptions of arm care and exercise advice after breast cancer surgery. Oncol Nurs Forum. 2010;37(1):85-91. https://doi.org/10.1188/10.ONF.85-91 .
doi: 10.1188/10.ONF.85-91
pubmed: 20044343